Dose optimization in oncology drug development is at the heart of the recent US FDA’s project Optimus initiative, to better satisfy the benefit:risk ratio for the patients as early as possible.

A new paradigm is emerging.

Join us for an insightful webinar on September 23, 2024 at 4.30 pm CET with 2 expert speakers, Gu Mi , Ph D (Biostatistics) and Laurent Nguyen, Pharm D, Ph D (Clinical PK and pharmacometrics), involved in oncology drug development.